Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry  | Primary Offense Type | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| Wyeth Pharmaceuticals Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $490,900,000 |
| Par Pharmaceutical Companies Inc. | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | FDA | $45,000,000 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $3,000,000,000 |
| Abbott Laboratories Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $1,500,000,000 |
| Merck, Sharp & Dohme | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $950,000,000 |
| Scios Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $85,000,000 |
| UCB Inc. | UCB | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $34,000,000 |
| Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | FDA | $164,000,000 |
| Elan Corporation PLC | Perrigo | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $203,000,000 |
| Eisai Inc. | Eisai | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $11,000,000 |
| SB Pharmco Puerto Rico Inc. | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2010 | FDA | $750,000,000 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $422,500,000 |
| Allergan Inc. | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $600,000,000 |
| Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $81,000,000 |
| Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $762,000,000 |
| Ranbaxy USA Inc. | Sun Pharmaceuticals | pharmaceuticals | drug or medical equipment safety violation | 2013 | FDA | $500,000,000 |
| Kos Pharmaceuticals | AbbVie | pharmaceuticals | kickbacks and bribery | 2010 | FDA | $41,500,000 |
| Pfizer H.C.P. Corporation | Pfizer | pharmaceuticals | Foreign Corrupt Practices Act | 2012 | DOJ_CRIMINAL | $15,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | Foreign Corrupt Practices Act | 2011 | DOJ_CRIMINAL | $21,400,000 |
| Warner Chilcott PLC | AbbVie | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | FDA | $125,000,000 |
| ISTA Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | False Claims Act and related | 2013 | DOJ_CIVIL | $33,500,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | drug or medical equipment safety violation | 2007 | DOJ_ANTITRUST | $1,000,000 |
| Hoechst AG | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | DOJ_ANTITRUST | $12,000,000 |
| Merck KgaA | Merck KGaA (EMD) | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | DOJ_ANTITRUST | $14,000,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $2,300,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | FDA | $1,415,000,000 |
| Cephalon Inc | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | FDA | $425,000,000 |
| Serono, S.A. | Merck KGaA (EMD) | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | FDA | $704,000,000 |
| Schering-Plough Corporation | Merck | pharmaceuticals | kickbacks and bribery | 2004 | DOJ_CIVIL | $345,000,000 |
| Warner-Lambert | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2004 | FDA | $430,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $354,900,000 |
| TAP Pharmaceutical Products Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | DOJ_CIVIL | $875,000,000 |
| Novo Nordisk A/S | Novo Holdings A/S | pharmaceuticals | kickbacks and bribery | 2009 | DOJ_CRIMINAL | $9,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2005 | FDA | $36,000,000 |
| Micrus Corporation | Johnson & Johnson | pharmaceuticals | Foreign Corrupt Practices Act | 2005 | DOJ_CRIMINAL | $450,000 |
| GNC Holdings Inc. | Harbin Pharmaceutical Group | pharmaceuticals | drug or medical equipment safety violation | 2016 | FDA | $2,250,000 |
| Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries | pharmaceuticals | Foreign Corrupt Practices Act | 2016 | DOJ_CRIMINAL | $283,177,348 |
| Aegerion Pharmaceuticals Inc. | Amryt Pharma | pharmaceuticals | drug or medical equipment safety violation | 2017 | DOJ_CIVIL | $35,000,000 |
| Abbott Laboratories and CG Nutritionals | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $600,000,000 |
| InterMune Inc. | Roche | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | FDA | $36,900,000 |
| Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | USAO | $410,000,000 |
| Synthes Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $669,800 |
| Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
| Biovail Pharmaceuticals Inc. | Bausch Health | pharmaceuticals | kickbacks and bribery | 2009 | USAO | $24,647,876 |
| Depuy Orthopaedics Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2007 | USAO | $84,700,000 |
| Jazz Pharmaceuticals Inc. | Jazz Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | USAO | $20,000,000 |
| Purdue Frederick Company Inc. | Purdue Pharma | pharmaceuticals | False Claims Act and related | 2007 | USAO | $600,000,000 |
| Pharmacia & Upjohn Company Inc. | Pfizer | pharmaceuticals | kickbacks and bribery | 2007 | USAO | $19,700,000 |
| Pharmacia & Upjohn Company LLC | Pfizer | pharmaceuticals | kickbacks and bribery | 2007 | USAO | $15,000,000 |
| Schering-Plough Corporation | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | USAO | $435,000,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | fraud | 2005 | USAO | $300,000,000 |
| ICN Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | fraud | 2001 | USAO | $5,600,000 |
| Roussel Uclaf S.A. | Sanofi | pharmaceuticals | drug or medical equipment safety violation | 2001 | USAO | $23,193,600 |
| Avanir Pharmaceuticals | Otsuka Pharmaceutical | pharmaceuticals | False Claims Act and related | 2019 | DOJ_CIVIL | $115,874,895 |
| Sandoz Inc. | Sandoz Group | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $195,000,000 |
| Apotex Corp. | Apotex Corp. | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | DOJ_ANTITRUST | $24,100,000 |
| Indivior Solutions | Indivior PLC | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $589,000,000 |
| Novartis Hellas S.A.C.I. et al. | Novartis | pharmaceuticals | Foreign Corrupt Practices Act | 2020 | DOJ_CRIMINAL | $233,000,000 |
| Purdue Pharma LP | Purdue Pharma | pharmaceuticals | fraud | 2020 | DOJ_CIVIL | $8,344,000,000 |
| Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $275,000,000 |
| Glenmark Pharmaceuticals Inc., USA | Glenmark Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $30,000,000 |
| Endo Health Solutions Inc. | Endo International | pharmaceuticals | drug or medical equipment safety violation | 2024 | DOJ_CIVIL | $464,900,000 |
| Kinder Morgan Bulk Terminals | Kinder Morgan | pipelines | air pollution violation | 2010 | EPA | $1,000,000 |
| Southern Union Company | Energy Transfer | pipelines | environmental violation | 2010 | EPA | $18,000,000 |
| Kinder Morgan Bulk Terminals Incorporated | Kinder Morgan | pipelines | water pollution violation | 2008 | EPA | $240,000 |
| Southern Union Company | Energy Transfer | pipelines | environmental violation | 2013 | EPA | $500,000 |
| Shore Terminals LLC | NuStar Energy | pipelines | air pollution violation | 2009 | USAO | $2,500,000 |
| Mid-America Pipeline Company, LLC | Mid-America Pipeline | pipelines | environmental violation | 2007 | USAO | $1,000,000 |
| Sunoco | Energy Transfer | pipelines | tax violations | 2021 | AL-AG | $122,314 |
| SFPP, L.P. | Kinder Morgan | pipelines | environmental violation | 2021 | CA-AG | $2,500,000 |
| Sunoco Pipeline L.P., and ETC Northeast Pipeline LLC | Energy Transfer | pipelines | environmental violation | 2022 | PA-AG | $10,000,000 |
| Columbus Steel Castings Company | Protostar Partners | private equity (including portfolio companies) | air pollution violation | 2011 | EPA | $825,000 |
| Hitachi Metals Ltd. | Bain Capital | private equity (including portfolio companies) | price-fixing or anti-competitive practices | 2014 | DOJ_ANTITRUST | $1,250,000 |
| MoneyGram International Inc. | Madison Dearborn Partners | private equity (including portfolio companies) | anti-money-laundering deficiencies | 2012 | DOJ_CRIMINAL | $100,000,000 |
| GEO Specialty Chemicals Inc. | Arsenal Capital Partners | private equity (including portfolio companies) | price-fixing or anti-competitive practices | 2016 | DOJ_ANTITRUST | $5,000,000 |
| Arctic Glacier International Inc. | Carlyle Group | private equity (including portfolio companies) | price-fixing or anti-competitive practices | 2009 | DOJ_ANTITRUST | $9,000,000 |
| Akzo Nobel Chemicals International B.V. | Carlyle Group | private equity (including portfolio companies) | price-fixing or anti-competitive practices | 2006 | DOJ_ANTITRUST | $32,000,000 |
| Akzo Nobel Chemicals BV | Carlyle Group | private equity (including portfolio companies) | price-fixing or anti-competitive practices | 2001 | DOJ_ANTITRUST | $12,000,000 |
| Reilly Industries Inc. | Wind Point Partners | private equity (including portfolio companies) | price-fixing or anti-competitive practices | 2000 | DOJ_ANTITRUST | $2,000,000 |
| America Online | Apollo Global Management | private equity (including portfolio companies) | accounting fraud or deficiencies | 2004 | DOJ_CRIMINAL | $210,000,000 |
| KIK (Virginia) LLC | Centerbridge Partners | private equity (including portfolio companies) | water pollution violation | 2009 | EPA | $100,000 |
| Acuity Specialty Products, Inc., | New Mountain Capital | private equity (including portfolio companies) | water pollution violation | 2007 | EPA | $3,800,000 |
| Boasso America Inc. | KKR & Co. | private equity (including portfolio companies) | hazardous waste violation | 2017 | USAO | $500,000 |
| Exactech Inc. | TPG Capital | private equity (including portfolio companies) | kickbacks and bribery | 2010 | USAO | $2,990,000 |
| Grede L.L.C. | Gamut Capital | private equity (including portfolio companies) | environmental violation | 2018 | USAO | $200,000 |
| MoneyGram International Inc. | Madison Dearborn Partners | private equity (including portfolio companies) | anti-money-laundering deficiencies | 2018 | DOJ_CRIMINAL | $125,000,000 |
| Covanta Tulsa Renewable Energy LLC | EQT AB | private equity (including portfolio companies) | environmental violation | 2018 | EPA | $200,000 |
| LifeScan Inc. | Platinum Equity | private equity (including portfolio companies) | drug or medical equipment safety violation | 2000 | USAO | $60,000,000 |
| Arctic Glacier International, Inc. | Carlyle Group | private equity (including portfolio companies) | price-fixing or anti-competitive practices | 2010 | MI-AG | $350,000 |
| Beverly Enterprises, Inc. | Fillmore Capital Partners | private equity (including portfolio companies) | nursing home violation | 2002 | CA-AG | $2,586,927 |
| Columbus Steel Castings Company, Inc. | Protostar Partners | private equity (including portfolio companies) | air pollution violation | 2011 | OH-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $825,000 |
| TruGreen LandCare | Clayton Dubilier & Rice | private equity (including portfolio companies) | workplace safety or health violation | 2001 | CA-SCCDA | $138,099 |
| Libertas Copper, LLC d/b/a Hussey Copper | KPS Capital Partners | private equity (including portfolio companies) | environmental violation | 2020 | EPA | $550,000 |
| Cytozyme Laboratories, Inc. | AEA Investors | private equity (including portfolio companies) | environmental violation | 2021 | UT-SLCDA | $2,000,000 |
| Oregon Tool, Inc. | Platinum Equity | private equity (including portfolio companies) | anti-money-laundering deficiencies | 2023 | USAO | $1,700,000 |
| Proterial Cable America, Inc. | Bain Capital | private equity (including portfolio companies) | motor vehicle safety violation | 2024 | DOJ_CRIMINAL | $15,126,204 |
| Pan Am Railways, Inc., Maine Central Railroad Co., Boston & Maine Corp., Springfield Terminal Railway Co. | CSX | railroads | environmental violation | 2009 | MA-AG | $500,000 |
| Trump Corp. | Trump Organization | real estate | tax violations | 2023 | NY-MANDA | $810,000 |
| Trump Payroll Corp. | Trump Organization | real estate | tax violations | 2023 | NY-MANDA | $800,000 |
| FHC Delaware, Inc. fka Fine Host Corporation | Aramark | restaurants and foodservice | False Claims Act and related | 2008 | USAO | $7,857,000 |
| Chipotle Mexican Grill Inc. | Chipotle Mexican Grill | restaurants and foodservice | food safety violation | 2020 | DOJ_CIVIL | $25,000,000 |
